An interventional study of Family Integrated Newborn Care, an intervention to integrate family in the care targeted their preterm and Low-birth weight neonates and Standard medical treatment in Family Involvement/Empowerment, Family-centered Care and Intensive Care Units, Neonatal, sponsored by Laerdal Foundation. Recruiting at 2 sites in Ethiopia. Per ClinicalTrials.gov, last updated 2026-01-23.
Sponsored by Laerdal Foundation · Not applicable, Interventional, and Supportive care
The goal of this quasi-experimental study is to learn if integrating family in newborn care units as a key partner can improve the outcomes of preterm and low-birth-weight neonates. The main question[s] that the study aims to answer:
In the intervention groups, family of preterm and low-birth-weight neonates will be trained, mentored, and integrated into the care targeted to their neonates.
The World Health Organization recommends Family involvement and support in the management of preterm and low birth weight neonates. However, the body of literature on its effectiveness in low-resource settings is scanty. The current study aimed to investigate the effectiveness of implementing Family-Integrated Newborn Care to improve outcomes for preterm and low-birth weight Neonates in resource-limited settings in resource-limited settings of Ethiopia. A quasi-experimental design with non-equivalent comparison groups will be employed among 1020 family-neonate dyads in three hospitals with level-2 Neonatal Care Units. The intervention package will mainly consist of training and education sessions for health care providers and families supplemented by measures to ensure infection prevention in level-2 neonatal care units. The effect size of implementing Family-Integrated Newborn Care on neonatal and parental outcomes will be estimated using General Linear Models (GLM) and compared with the conventional care. Research questions are:
154 studies on the registry are indexed under Empowerment; 31 are open to participants now.
This study's planned enrollment of 1,020 is above the median of 141 across 132 interventional studies indexed under Empowerment.
Browse Empowerment studies →This is the only study on the registry with Laerdal Foundation as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This arm includes the family of the neonates assigned to the experimental group, and they will receive a FINC intervention. The FINC intervention, families of preterm and low-birth weight neonates aged 0-28 days will be trained, educated, and encouraged to get involved in the newborn care targeted to their neonates.
Behavioral: Family Integrated Newborn Care, an intervention to integrate family in the care targeted their preterm and Low-birth weight neonates
This arm includes the families of the neonates assigned to the comparator group, who will receive conventional or standard care. No special effort that the routine care will be provided to integrate the family into the care targeted to the preterm and low-birth-weight neonates
Behavioral: Standard medical treatment
The Family Integrated Newborn Care intervention includes undergoing 1) minor modifications in the NCU space and physical infrastructure conducive to family integration; 2) bedside training for families, and 3) provision of ten audio-visual materials in the local language (Tigrigna) demonstrating family integration in key caring activities targeted to their neonates.
Also known as: Family-Centered care, Family Involvement
The preterm and low-birth weight neonates will receive the conventional care with no special attention to integrate the families in the care targeted to the neonates
Also known as: Conventional newborn care
Length of hospital stay
It refers to the duration a neonate stays in the hospital for care, starting from admission to discharge home
Time frame: The period from the date of admission to the date of discharge is within the first 28 days of neonat's life.
Survival at discharge
Survival status of the neonate at discharge, specified as alive, dead, or referred for higher-level care, or left against medical advice.
Time frame: Starting from date of admission to the date of discharge within the first 28 days of the neonate's life
Daily weight gain
The net weight gain of a neonate each day (in grams/kg/day) in reference to the expected gain for the body mass
Time frame: Starting from the date of admission up to the date of discharge and assessed in the first 28 days of the neonate's life
Time to initiate breastfeeding after admission
The time the breastfeeding of the neonate is initiated for the first time since admission
Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life
Time to initiate skin-to-skin after admission
The first time skin-to-skin is initiated for the neonate, since the date of admission to the Neonatal Intensive Care Unit (NICU)
Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life
The number of days on Antibiotics
The total number of days the neonate received antibiotics for being suspected or diagnosed with sepsis
Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life
Score for parental stress monitoring scale
A score for the parental stress monitoring scale, which consists of eight items in a five-point Likert scale, with scores ranging from a lower score (1= Not stressful at all) to a higher score (5= Extremely stressful).
Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life
Discharge readiness score on the day of the discharge
The score for the discharge readiness scale, consisting of eight items in a five-point Likert scale, to assess parents' readiness at the time of discharge. The score level ranges from a lower score (1= Extremely low confidence) to a higher score (5= Extremely high confidence).
Time frame: Starting from the date of admission to the date of discharge, within the first 28 days of the neonate's life
Plan to share: Yes — The study is part of a PhD study. The dataset consists of inpatient data will be shared after the manuscript summarizing the key findings of the trial is published. Hence, the dataset will be made available open for the public in June 2027. In addition, the IPD can be shared up on reasonable request form the contact person of the study.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: June 2027, one year after the completion of the trial
Access criteria: The IPD will be available in the data repository for Mekelle University based on the notification to the contact person of the study
Data sharing details ↗ · repository.mu.edu.et
Started Dec 2025 (actual). Primary completion is estimated for Jun 2026, 5 months after the start.
Of 82 non-industry interventional studies with no phase under Empowerment, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 5 months is below that.
Counting every sponsor, half of 82 studies reached it within 22 months; a quarter within 11 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.